Positron Emission Tomography Imaging of Cancer Biology: Current Status and Future Prospects
- 1 February 2011
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 38 (1) , 70-86
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Biomedical Imaging and Bioengineering
This publication has 126 references indexed in Scilit:
- Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific [ 18 F]-labeled isatin sulfonamideProceedings of the National Academy of Sciences, 2009
- Molecular imaging of hypoxia with radiolabelled agentsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2009
- Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesisProceedings of the National Academy of Sciences, 2009
- Autoradiographic and small-animal PET comparisons between 18F-FMISO, 18F-FDG, 18F-FLT and the hypoxic selective 64Cu-ATSM in a rodent model of cancerNuclear Medicine and Biology, 2008
- Site-Specific Labeling of Annexin V with F-18 for Apoptosis ImagingBioconjugate Chemistry, 2008
- Imaging of VEGF Receptor in a Rat Myocardial Infarction Model Using PETJournal of Nuclear Medicine, 2008
- pO polarography, contrast enhanced color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography: validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the puzzle of tumor hypoxia?BMC Cancer, 2007
- ERBB receptors and cancer: the complexity of targeted inhibitorsNature Reviews Cancer, 2005
- Noninvasive Visualization of the Activated αvβ3 Integrin in Cancer Patients by Positron Emission Tomography and [18F]Galacto-RGDPLOS Medicine, 2005
- Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and AngiogenesisJournal of Clinical Oncology, 2005